{"count":220771,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=746","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=744","results":[{"created":"2022-09-23T11:52:08.686494+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.156","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: BAAT: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Bile acid conjugation defect 1, MIM# 619232; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"BAAT","entity_type":"gene"},{"created":"2022-09-23T11:49:40.348992+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.156","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: B3GLCT as ready","entity_name":"B3GLCT","entity_type":"gene"},{"created":"2022-09-23T11:49:40.340182+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.156","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: b3glct has been classified as Red List (Low Evidence).","entity_name":"B3GLCT","entity_type":"gene"},{"created":"2022-09-23T11:48:36.197536+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.156","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: B3GLCT were changed from Peters-Plus syndrome to Peters-plus syndrome, MIM#261540","entity_name":"B3GLCT","entity_type":"gene"},{"created":"2022-09-23T11:48:24.496336+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.155","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: B3GLCT as Red List (low evidence)","entity_name":"B3GLCT","entity_type":"gene"},{"created":"2022-09-23T11:48:24.487925+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.155","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: b3glct has been classified as Red List (Low Evidence).","entity_name":"B3GLCT","entity_type":"gene"},{"created":"2022-09-23T11:48:14.112179+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.154","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: B3GLCT: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Peters-plus syndrome, MIM#261540; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"B3GLCT","entity_type":"gene"},{"created":"2022-09-23T11:45:58.046208+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.154","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BBS9 as ready","entity_name":"BBS9","entity_type":"gene"},{"created":"2022-09-23T11:45:58.034751+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.154","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs9 has been classified as Red List (Low Evidence).","entity_name":"BBS9","entity_type":"gene"},{"created":"2022-09-23T11:45:53.367165+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.154","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BBS9 were changed from Bardet-Biedl syndrome to Bardet-Biedl syndrome 9, MIM#615986","entity_name":"BBS9","entity_type":"gene"},{"created":"2022-09-23T11:45:35.241339+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.153","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BBS9 as Red List (low evidence)","entity_name":"BBS9","entity_type":"gene"},{"created":"2022-09-23T11:45:35.232016+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.153","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs9 has been classified as Red List (Low Evidence).","entity_name":"BBS9","entity_type":"gene"},{"created":"2022-09-23T11:45:23.650775+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.152","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: BBS9: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Bardet-Biedl syndrome 9, MIM#615986; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"BBS9","entity_type":"gene"},{"created":"2022-09-23T11:44:06.671342+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.152","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BBS7 as ready","entity_name":"BBS7","entity_type":"gene"},{"created":"2022-09-23T11:44:06.654199+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.152","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs7 has been classified as Red List (Low Evidence).","entity_name":"BBS7","entity_type":"gene"},{"created":"2022-09-23T11:43:58.879519+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.152","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BBS7 were changed from Bardet-Biedl syndrome to Bardet-Biedl syndrome 7, MIM# 615984","entity_name":"BBS7","entity_type":"gene"},{"created":"2022-09-23T11:40:36.094980+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.151","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BBS7 as Red List (low evidence)","entity_name":"BBS7","entity_type":"gene"},{"created":"2022-09-23T11:40:36.084875+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.151","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs7 has been classified as Red List (Low Evidence).","entity_name":"BBS7","entity_type":"gene"},{"created":"2022-09-23T11:37:58.545906+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.150","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: BBS7: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Bardet-Biedl syndrome 7, MIM# 615984; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"BBS7","entity_type":"gene"},{"created":"2022-09-23T11:30:35.994362+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.150","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BBS5 as ready","entity_name":"BBS5","entity_type":"gene"},{"created":"2022-09-23T11:30:35.984465+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.150","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs5 has been classified as Red List (Low Evidence).","entity_name":"BBS5","entity_type":"gene"},{"created":"2022-09-23T11:30:28.050735+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.150","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BBS5 were changed from Bardet-Biedl syndrome to Bardet-Biedl syndrome 5, MIM#615983","entity_name":"BBS5","entity_type":"gene"},{"created":"2022-09-23T11:30:16.825434+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.149","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BBS5 as Red List (low evidence)","entity_name":"BBS5","entity_type":"gene"},{"created":"2022-09-23T11:30:16.801571+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.149","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs5 has been classified as Red List (Low Evidence).","entity_name":"BBS5","entity_type":"gene"},{"created":"2022-09-23T11:30:03.651142+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.148","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: BBS5: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Bardet-Biedl syndrome 5, MIM#615983; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"BBS5","entity_type":"gene"},{"created":"2022-09-23T11:28:31.934049+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.148","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BBS4 as ready","entity_name":"BBS4","entity_type":"gene"},{"created":"2022-09-23T11:28:31.922994+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.148","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs4 has been classified as Red List (Low Evidence).","entity_name":"BBS4","entity_type":"gene"},{"created":"2022-09-23T11:28:27.977605+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.148","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BBS4 were changed from Bardet-Biedl syndrome to Bardet-Biedl syndrome 4, MIM#615982","entity_name":"BBS4","entity_type":"gene"},{"created":"2022-09-23T11:28:15.970345+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.147","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BBS4 as Red List (low evidence)","entity_name":"BBS4","entity_type":"gene"},{"created":"2022-09-23T11:28:15.944299+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.147","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs4 has been classified as Red List (Low Evidence).","entity_name":"BBS4","entity_type":"gene"},{"created":"2022-09-23T11:28:03.967280+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: BBS4: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Bardet-Biedl syndrome 4, MIM#615982; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"BBS4","entity_type":"gene"},{"created":"2022-09-23T11:26:37.358059+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BBS2 as ready","entity_name":"BBS2","entity_type":"gene"},{"created":"2022-09-23T11:26:37.345340+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs2 has been classified as Red List (Low Evidence).","entity_name":"BBS2","entity_type":"gene"},{"created":"2022-09-23T11:26:33.947388+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BBS2 were changed from Bardet-Biedl syndrome to Bardet-Biedl syndrome 2, MIM# 615981","entity_name":"BBS2","entity_type":"gene"},{"created":"2022-09-23T11:26:20.949320+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.145","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BBS2 as Red List (low evidence)","entity_name":"BBS2","entity_type":"gene"},{"created":"2022-09-23T11:26:20.939748+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.145","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs2 has been classified as Red List (Low Evidence).","entity_name":"BBS2","entity_type":"gene"},{"created":"2022-09-23T11:26:08.880606+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.144","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: BBS2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Bardet-Biedl syndrome 2, MIM# 615981; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"BBS2","entity_type":"gene"},{"created":"2022-09-23T11:25:01.500537+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.144","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BBS12 as ready","entity_name":"BBS12","entity_type":"gene"},{"created":"2022-09-23T11:25:01.447301+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.144","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs12 has been classified as Red List (Low Evidence).","entity_name":"BBS12","entity_type":"gene"},{"created":"2022-09-23T11:24:58.019488+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.144","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BBS12 were changed from Bardet-Biedl syndrome to Bardet-Biedl syndrome 12, MIM# 615989","entity_name":"BBS12","entity_type":"gene"},{"created":"2022-09-23T11:24:45.562911+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.143","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BBS12 as Red List (low evidence)","entity_name":"BBS12","entity_type":"gene"},{"created":"2022-09-23T11:24:45.548340+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.143","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs12 has been classified as Red List (Low Evidence).","entity_name":"BBS12","entity_type":"gene"},{"created":"2022-09-23T11:24:33.435428+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: BBS12: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Bardet-Biedl syndrome 12, MIM# 615989; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"BBS12","entity_type":"gene"},{"created":"2022-09-23T11:21:09.865125+10:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"1.70","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PDCD6IP were changed from Primary microcephaly to Microcephaly 29, primary, autosomal recessive, MIM# 620047","entity_name":"PDCD6IP","entity_type":"gene"},{"created":"2022-09-23T11:20:54.110008+10:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"1.69","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PDCD6IP: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Microcephaly 29, primary, autosomal recessive, MIM# 620047; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PDCD6IP","entity_type":"gene"},{"created":"2022-09-23T11:19:33.671539+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4947","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PDCD6IP were changed from Primary microcephaly to Microcephaly 29, primary, autosomal recessive, MIM# 620047","entity_name":"PDCD6IP","entity_type":"gene"},{"created":"2022-09-23T11:18:57.802508+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4946","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PDCD6IP: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Microcephaly 29, primary, autosomal recessive, MIM# 620047; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PDCD6IP","entity_type":"gene"},{"created":"2022-09-23T11:18:30.445441+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.153","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PDCD6IP were changed from Primary microcephaly to Microcephaly 29, primary, autosomal recessive, MIM# 620047","entity_name":"PDCD6IP","entity_type":"gene"},{"created":"2022-09-23T11:18:00.084210+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.152","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: PDCD6IP: Changed rating: AMBER; Changed phenotypes: Microcephaly 29, primary, autosomal recessive, MIM# 620047; Changed mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PDCD6IP","entity_type":"gene"},{"created":"2022-09-23T11:17:28.331287+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.341","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PDCD6IP were changed from Neurodevelopmental disorder MONDO:0700092; Microcephaly; intellectual disability to Microcephaly 29, primary, autosomal recessive, MIM# 620047; Microcephaly; intellectual disability","entity_name":"PDCD6IP","entity_type":"gene"},{"created":"2022-09-23T11:16:53.973908+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.340","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: PDCD6IP: Changed phenotypes: Microcephaly 29, primary, autosomal recessive, MIM# 620047, Microcephaly, intellectual disability","entity_name":"PDCD6IP","entity_type":"gene"},{"created":"2022-09-23T11:16:41.794444+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.340","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: PDCD6IP: Changed phenotypes: Microcephaly 29, primary, autosomal recessive , MIM# 620047, Microcephaly, intellectual disability","entity_name":"PDCD6IP","entity_type":"gene"},{"created":"2022-09-22T19:03:27.078238+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BBS10 as ready","entity_name":"BBS10","entity_type":"gene"},{"created":"2022-09-22T19:03:27.066049+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs10 has been classified as Red List (Low Evidence).","entity_name":"BBS10","entity_type":"gene"},{"created":"2022-09-22T19:03:16.794321+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BBS10 were changed from Bardet-Biedl syndrome to Bardet-Biedl syndrome 10, MIM# 615987","entity_name":"BBS10","entity_type":"gene"},{"created":"2022-09-22T19:03:01.234559+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.141","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BBS10 as Red List (low evidence)","entity_name":"BBS10","entity_type":"gene"},{"created":"2022-09-22T19:03:01.223562+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.141","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs10 has been classified as Red List (Low Evidence).","entity_name":"BBS10","entity_type":"gene"},{"created":"2022-09-22T19:02:49.868360+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.140","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: BBS10: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Bardet-Biedl syndrome 10, MIM# 615987; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"BBS10","entity_type":"gene"},{"created":"2022-09-22T18:43:04.763092+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.340","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DPP9 as ready","entity_name":"DPP9","entity_type":"gene"},{"created":"2022-09-22T18:43:04.753598+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.340","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dpp9 has been classified as Green List (High Evidence).","entity_name":"DPP9","entity_type":"gene"},{"created":"2022-09-22T18:42:29.656640+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.340","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DPP9 as Green List (high evidence)","entity_name":"DPP9","entity_type":"gene"},{"created":"2022-09-22T18:42:29.648386+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.340","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dpp9 has been classified as Green List (High Evidence).","entity_name":"DPP9","entity_type":"gene"},{"created":"2022-09-22T18:42:12.002936+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.339","user_name":"Zornitza Stark","item_type":"entity","text":"gene: DPP9 was added\ngene: DPP9 was added to Mendeliome. Sources: Expert Review\nMode of inheritance for gene: DPP9 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: DPP9 were set to 36112693\nPhenotypes for gene: DPP9 were set to Autoinflammatory syndrome MONDO:0019751, DPP9-related; recurrent fevers; repeated infections; herpes susceptibility; cytopenias\nReview for gene: DPP9 was set to GREEN\nAdded comment: Three unrelated families with Hatipoğlu syndrome with biochemical and cellular assays, mouse and zebrafish models. Immunological features of recurrent fevers, repeated infections, herpes susceptibility, cytopenias. \nSources: Expert Review","entity_name":"DPP9","entity_type":"gene"},{"created":"2022-09-22T18:39:26.881672+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.166","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DPP9 as ready","entity_name":"DPP9","entity_type":"gene"},{"created":"2022-09-22T18:39:26.871475+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.166","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dpp9 has been classified as Green List (High Evidence).","entity_name":"DPP9","entity_type":"gene"},{"created":"2022-09-22T18:39:23.591764+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.166","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DPP9 were changed from recurrent fevers; repeated infections; herpes susceptibility; cytopaenias to Autoinflammatory syndrome MONDO:0019751, DPP9-related; recurrent fevers; repeated infections; herpes susceptibility; cytopaenias","entity_name":"DPP9","entity_type":"gene"},{"created":"2022-09-22T18:38:22.862071+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.165","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DPP9 as Green List (high evidence)","entity_name":"DPP9","entity_type":"gene"},{"created":"2022-09-22T18:38:22.854190+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.165","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dpp9 has been classified as Green List (High Evidence).","entity_name":"DPP9","entity_type":"gene"},{"created":"2022-09-22T18:35:12.256410+10:00","panel_name":"Dystonia - complex","panel_id":290,"panel_version":"0.217","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: AFG3L2 were set to 22964162; 16541453; 32219868","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T18:34:54.370129+10:00","panel_name":"Dystonia - complex","panel_id":290,"panel_version":"0.216","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AFG3L2 as Amber List (moderate evidence)","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T18:34:54.360607+10:00","panel_name":"Dystonia - complex","panel_id":290,"panel_version":"0.216","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: afg3l2 has been classified as Amber List (Moderate Evidence).","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T18:31:41.518859+10:00","panel_name":"Early-onset Parkinson disease","panel_id":26,"panel_version":"0.236","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AFG3L2 were changed from  to Spinocerebellar ataxia 28, MIM# 610246; optic atrophy; spastic ataxia; L-dopa-responsive parkinsonism","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T18:31:19.795745+10:00","panel_name":"Early-onset Parkinson disease","panel_id":26,"panel_version":"0.236","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: AFG3L2 were set to ","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T18:29:04.614377+10:00","panel_name":"Early-onset Parkinson disease","panel_id":26,"panel_version":"0.235","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AFG3L2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T18:27:52.096492+10:00","panel_name":"Early-onset Parkinson disease","panel_id":26,"panel_version":"0.234","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AFG3L2 as Amber List (moderate evidence)","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T18:27:52.088747+10:00","panel_name":"Early-onset Parkinson disease","panel_id":26,"panel_version":"0.234","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: afg3l2 has been classified as Amber List (Moderate Evidence).","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T18:16:39.072791+10:00","panel_name":"Early-onset Parkinson disease","panel_id":26,"panel_version":"0.233","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AFG3L2 as Amber List (moderate evidence)","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T18:16:39.063697+10:00","panel_name":"Early-onset Parkinson disease","panel_id":26,"panel_version":"0.233","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: afg3l2 has been classified as Amber List (Moderate Evidence).","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T18:15:59.563765+10:00","panel_name":"Early-onset Parkinson disease","panel_id":26,"panel_version":"0.232","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: AFG3L2: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Spinocerebellar ataxia 28, MIM# 610246; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2022-09-22T17:39:07.071406+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.140","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BBS1 as ready","entity_name":"BBS1","entity_type":"gene"},{"created":"2022-09-22T17:39:07.060647+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.140","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs1 has been classified as Red List (Low Evidence).","entity_name":"BBS1","entity_type":"gene"},{"created":"2022-09-22T17:39:03.814197+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.140","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BBS1 were changed from Bardet-Biedl syndrome to Bardet-Biedl syndrome 1, MIM# 209900","entity_name":"BBS1","entity_type":"gene"},{"created":"2022-09-22T17:38:49.213529+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.139","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BBS1 as Red List (low evidence)","entity_name":"BBS1","entity_type":"gene"},{"created":"2022-09-22T17:38:49.205102+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.139","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bbs1 has been classified as Red List (Low Evidence).","entity_name":"BBS1","entity_type":"gene"},{"created":"2022-09-22T17:38:37.073384+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.138","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: BBS1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Bardet-Biedl syndrome 1, MIM# 209900; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"BBS1","entity_type":"gene"},{"created":"2022-09-22T17:36:05.058135+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.338","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: ATP6V1B1.","entity_name":"ATP6V1B1","entity_type":"gene"},{"created":"2022-09-22T17:35:55.668469+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.138","user_name":"Zornitza Stark","item_type":"entity","text":"Tag for review tag was added to gene: ATP6V1B1.\nTag treatable tag was added to gene: ATP6V1B1.","entity_name":"ATP6V1B1","entity_type":"gene"},{"created":"2022-09-22T17:35:40.680036+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.138","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ATP6V1B1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Distal renal tubular acidosis 2 with progressive sensorineural hearing loss, MIM# 267300; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ATP6V1B1","entity_type":"gene"},{"created":"2022-09-22T17:30:55.100018+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.338","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: ATP6V0A4.","entity_name":"ATP6V0A4","entity_type":"gene"},{"created":"2022-09-22T17:30:24.923202+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.138","user_name":"Zornitza Stark","item_type":"entity","text":"Tag for review tag was added to gene: ATP6V0A4.\nTag treatable tag was added to gene: ATP6V0A4.","entity_name":"ATP6V0A4","entity_type":"gene"},{"created":"2022-09-22T17:30:10.903587+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.138","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ATP6V0A4: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Renal tubular acidosis, distal, autosomal recessive, MIM#602722; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ATP6V0A4","entity_type":"gene"},{"created":"2022-09-22T17:24:51.037712+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.138","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ATP6V0A2 as ready","entity_name":"ATP6V0A2","entity_type":"gene"},{"created":"2022-09-22T17:24:51.023137+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.138","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: atp6v0a2 has been classified as Red List (Low Evidence).","entity_name":"ATP6V0A2","entity_type":"gene"},{"created":"2022-09-22T17:24:46.898653+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.138","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ATP6V0A2 were changed from Cutis laxa, autosomal recessive, type IIA to Cutis laxa, autosomal recessive, type IIA, MIM# 219200; Wrinkly skin syndrome, MIM#278250","entity_name":"ATP6V0A2","entity_type":"gene"},{"created":"2022-09-22T17:24:24.100520+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.137","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ATP6V0A2 as Red List (low evidence)","entity_name":"ATP6V0A2","entity_type":"gene"},{"created":"2022-09-22T17:24:24.090392+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.137","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: atp6v0a2 has been classified as Red List (Low Evidence).","entity_name":"ATP6V0A2","entity_type":"gene"},{"created":"2022-09-22T17:24:13.632383+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.136","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ATP6V0A2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Cutis laxa, autosomal recessive, type IIA, MIM# 219200, Wrinkly skin syndrome, MIM#278250; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ATP6V0A2","entity_type":"gene"},{"created":"2022-09-22T17:22:12.665805+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.136","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ATP2A1 as ready","entity_name":"ATP2A1","entity_type":"gene"},{"created":"2022-09-22T17:22:12.652156+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.136","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: atp2a1 has been classified as Red List (Low Evidence).","entity_name":"ATP2A1","entity_type":"gene"},{"created":"2022-09-22T17:22:04.095174+10:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.136","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ATP2A1 were changed from Brody myopathy to Brody myopathy, OMIM # 601003","entity_name":"ATP2A1","entity_type":"gene"}]}